A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2

The role of the cytokine interleukin-37 (IL-37) has been recognized in reversing inflammation-mediated metabolic costs. The aim was to evaluate the clinical utility of this cytokine as a diagnostic and prognostic marker in patients with type 2 diabetes (T2D). We included 170 older (median: 66 years)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of environmental research and public health 2023-02, Vol.20 (4), p.3695
Hauptverfasser:	Bosnić, Zvonimir, Babič, František, Anderková, Viera, Štefanić, Mario, Wittlinger, Thomas, Majnarić, Ljiljana Trtica
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - therapeutic use Anti-inflammatory drugs Biomarkers C-reactive protein Cardiovascular disease Case studies Complications Cytokines Cytokines - metabolism Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Diabetic retinopathy Diabetics Diagnostic systems Female Frailty Health care Humans Hypertension Inflammation Inflammation - metabolism Interleukins Laboratories Malnutrition Medical research Medicine, Experimental Metabolic disorders Metabolic syndrome Metabolism Nutritional status Obesity Pathophysiology Patients Primary care Prognosis Regression analysis Statistical analysis Subgroups Type 2 diabetes Vein & artery diseases Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!